138 related articles for article (PubMed ID: 19631998)
1. Signal pathways involved in reverse remodeling of the hypertrophic rat heart after pressure unloading.
Xu R; Lin F; Zhang S; Chen X; Hu S; Zheng Z
Int J Cardiol; 2010 Sep; 143(3):414-23. PubMed ID: 19631998
[TBL] [Abstract][Full Text] [Related]
2. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
[TBL] [Abstract][Full Text] [Related]
3. Unloading-induced remodeling in the normal and hypertrophic left ventricle.
McGowan BS; Scott CB; Mu A; McCormick RJ; Thomas DP; Margulies KB
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2061-8. PubMed ID: 12573997
[TBL] [Abstract][Full Text] [Related]
4. [miRNA changes in the reverse remodeling heart of rats].
Wang J; Zheng Z; Lin FQ; Sun CC; Xu RX; Hu SS
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):745-50. PubMed ID: 21055145
[TBL] [Abstract][Full Text] [Related]
5. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
Voloshenyuk TG; Gardner JD
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
[TBL] [Abstract][Full Text] [Related]
6. Exogenous ubiquitin modulates chronic β-adrenergic receptor-stimulated myocardial remodeling: role in Akt activity and matrix metalloproteinase expression.
Daniels CR; Foster CR; Yakoob S; Dalal S; Joyner WL; Singh M; Singh K
Am J Physiol Heart Circ Physiol; 2012 Dec; 303(12):H1459-68. PubMed ID: 23042947
[TBL] [Abstract][Full Text] [Related]
7. The effect of angoroside C on pressure overload-induced ventricular remodeling in rats.
Gu WL; Chen CX; Huang XY; Gao JP
Phytomedicine; 2015 Jul; 22(7-8):705-12. PubMed ID: 26141756
[TBL] [Abstract][Full Text] [Related]
8. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
9. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Chen DD; Dong YG; Liu D; He JG
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory kappa-B kinase-β inhibition prevents adaptive left ventricular hypertrophy.
Andersen NM; Tang R; Li L; Javan H; Zhang XQ; Selzman CH
J Surg Res; 2012 Nov; 178(1):105-9. PubMed ID: 22464396
[TBL] [Abstract][Full Text] [Related]
12. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal.
Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH
Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545
[TBL] [Abstract][Full Text] [Related]
13. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H
J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823
[TBL] [Abstract][Full Text] [Related]
14. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
Deres L; Bartha E; Palfi A; Eros K; Riba A; Lantos J; Kalai T; Hideg K; Sumegi B; Gallyas F; Toth K; Halmosi R
PLoS One; 2014; 9(7):e102148. PubMed ID: 25014216
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.
Sabri A; Rafiq K; Seqqat R; Kolpakov MA; Dillon R; Dell'italia LJ
Circ Res; 2008 May; 102(9):1127-36. PubMed ID: 18356543
[TBL] [Abstract][Full Text] [Related]
16. Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia.
Strnisková M; Ravingerová T; Neckár J; Kolár F; Pastoreková S; Barancík M
Gen Physiol Biophys; 2006 Mar; 25(1):25-41. PubMed ID: 16714773
[TBL] [Abstract][Full Text] [Related]
17. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart.
Weng YC; Chuang CF; Chuang ST; Chiu HL; Kuo YH; Su MJ
Eur J Pharmacol; 2012 Jun; 684(1-3):108-15. PubMed ID: 22484506
[TBL] [Abstract][Full Text] [Related]
18. Dynamic expression profiles of MMPs/TIMPs and collagen deposition in mechanically unloaded rat heart: implications for left ventricular assist device support-induced cardiac alterations.
Wang L; Xu YX; Du XJ; Sun QG; Tian YJ
J Physiol Biochem; 2013 Sep; 69(3):477-85. PubMed ID: 23315238
[TBL] [Abstract][Full Text] [Related]
19. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart.
Wang J; Xu R; Lin F; Zhang S; Zhang G; Hu S; Zheng Z
Cardiology; 2009; 113(2):81-8. PubMed ID: 19018142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
